Project Grant R35GM163771
- Federal Grant Award Summary The University of California, San Francisco received a $501,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 5, 2025, with completion expected May 31, 2030. This five-year research initiative focuses on bridging the gap between predicted and experimentally determined atomic structures in structural biology. The project will develop...
- Federal Grant Award Summary The University of California, San Diego received a $638,334 Project Grant award dated September 8, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to develop innovative computational drug design technologies. The project, scheduled for completion by August 31, 2027, focuses on advancing understanding of protein-small molecule binding mechanisms by creating novel computational...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS), through its Biomedical Research and Research Training program (CFDA 93.859), awarded $150,104 to the University of California, San Francisco on August 8, 2026, for a Project Grant focused on de novo protein design. The research aims to engineer allosterically regulated proteins capable of intramolecular signal transduction—a fundamental process governing central metabolism, genetic regulatory networks, and...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Berkeley $401,250 under the Biomedical Research and Research Training program (CFDA 93.859) on September 15, 2025, for a project extending through July 31, 2030. The award supports the development of an integrated computational framework combining machine learning potentials (MLPs), atomistic simulations, and data-driven models to predict the solubility of drug-related...
- Federal Grant Award Summary The University of California, Davis received a $341,970 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 15, 2026, with a completion date of February 28, 2030. This award supports the development of polarizable Gaussian multipole force fields for biomolecular simulations based on in-solution electrostatics. The research team will develop and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $124,767 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) for a two-year period commencing May 1, 2026 and concluding April 30, 2028. This award supports de novo protein design research focused on developing computationally designed proteins that bind small molecules and catalyze chemical...
- Federal Project Grant Award Summary The University of California, San Francisco received a $562,484 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) for the five-year period from May 1, 2026, through April 30, 2031. This award supports the development of next-generation visualization and analysis software tools designed to enable scientific discovery in biomedical research. The software will...
- Federal Grant Award Summary The University of California, San Diego received a $347,086 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds a five-year research initiative focused on developing precision, functional glyconanoassemblies through supramolecular design. The research aims to advance synthetic glycan assembly...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Berkeley $361,952 through the Biomedical Research and Research Training program (CFDA 93.859) to develop experimental and computational methods for systematic exploration of protein sequence-function relationships. Beginning September 1, 2025, and concluding June 30, 2030, this project delivers research focused on mapping mutational landscapes of biomedically...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
The University of California, Santa Barbara received a $391,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through April 30, 2031. This research award supports the development of advanced computational methodologies to study liquid-liquid phase separation (LLPS) of intrinsically disordered proteins (IDPs), which form biomolecular condensates critical to physiological functions but capable of transitioning into disease-associated amyloid fibrils under aberrant conditions. The project delivers three primary research outputs: (1) a multiscale computational framework integrating atomistic simulations with field theoretic modeling to generate accurate phase diagrams for tau protein and elastin-like polypeptides, with results backmapped to generate experimentally comparable solvated condensate structures; (2) development of high-pressure Kirkwood-Buff force fields for osmolytes and their application to studying high-pressure denaturation mechanisms; and (3) artificial intelligence protein language model tools designed to identify new LLPS-prone sequences within the human proteome. These integrated research products advance fundamental understanding of how water, co-solvents, and pressure modulate biomolecular assembly and condensate formation, establishing computational foundations for potential therapeutic applications in disease prevention and diagnosis. The award represents NIGMS's commitment to supporting investigator-initiated basic research that increases understanding of biological processes and provides the foundation for advances in disease treatment and prevention.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $391.3k | 4/13/26 |